Scientific Publications and Presentations

Science That Moves Neuroscience Forward

Our scientific publications reflect our commitment to advancing neuroscience through rigorous research, transparent data sharing, and ongoing collaboration with the scientific community.

Search Facet
Focus Area Filter Dropdown
Year Filter - Dropdown
Meeting Filter - Dropdown
MDS Congress | 2026

Ulixacaltamide Demonstrates Superiority Over Placebo as Monotherapy and as Add-on to Propranolol in EssentialTremor: Phase 3 ESSENTIAL3 Study 1

MDS Congress | 2026

Framework for Future Neurology Trials: Enhanced Scientific Rigor Through Innovative Decentralized Trial Methodology

MDS Congress | 2026

Ulixacaltamide Demonstrates Broad Functional Improvement Across Individual Domains of Activities of Daily Living in Essential Tremor

EEC Meeting | 2026

Elsunersen, a Novel Antisense Oligonucleotide, Shows Marked Seizure Reduction and Broad Functional Improvements Highlighting Disease-Modifying Potential in Early Onset SCN2A Developmental and Epileptic Encephalopathy: Results from the EMBRAVE Part A Study

EEC Meeting | 2026

Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants

EEC Meeting | 2026

High Seizure Burden and Limited Treatment Persistence in Epilepsy: Findings from the EMPOWER Observational Study and a US Real-World Claims Analysis

EEC Meeting | 2026

POWER1 – A Double-Blind, Randomized, Multicenter Registrational Study Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Onset Seizures

EEC Meeting | 2026

Vormatrigine Rapidly Reduces Seizures in Adults with Treatment-Resistant Epilepsy: Results from the RADIANT Study

EEC Meeting | 2026

Vormatrigine Exhibits a Favorable Drug-Drug Interaction Profile Supporting Broad Combination Use with Antiseizure Medications

EEC Meeting | 2026

Efficacy and Safety of Relutrigine in Pediatric Participants with SCN2A- and SCN8A-Related Developmental and Epileptic Encephalopathies: Results from the EMBOLD Study

Explore More